On February 14th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 220.66K options for the day, of which put options accounted for 33.58% of the total transactions, Futu NewsFeb 15 05:30 Trending Stocks Heat List No. Symbol Price NVIDIA NVDA 138.850 ...
MRNA Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -64.28% Moderna, Inc. price and volume Combination chart with 2 data series. Chart represents Moderna, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displ...
MRNA | Complete Moderna Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get Moderna Inc (MRNA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
DeepSeek Sell-off Offers Opportunities On Semicaps, Analyst Bumps Up Price Forecasts For KLA, Nova And Camtek Jan. 28, 2025 at 3:01 p.m. ET on Benzinga.com What's in Store for These 4 Electronic Stocks This Earnings Season? Jan. 28, 2025 at 12:40 p.m. ET on Zacks.com Ke...
Below is Validea's guru fundamental report for MODERNA INC (MRNA). Of the 22 guru strategies we follow, MRNA rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks
Moderna Faces Challenges, MRNA Stock Continues YTD Decline Feb 17, 2025 · 2 min read PureCycle Stock PCT Up 15% Feb 14, 2025 · 2 min read Airbnb Reports Strong Q4 Growth, Stock Climbs Feb 14, 2025 · 2 min read Nu Skin Faces Challenges with Cautious 2025 Outlook Feb 13, 2025...
Get the latest Pfizer Inc. (PFE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Biotech and Pharma GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines Jul. 3, 2024 at 10:18 a.m. ET by Barron's CureVac’s stock soars on GSK’s $1.56 billion deal for its COVID-19 and flu vaccines Jul. 3, 2024 at 7:53 a.m. ET by Barbara Kollmeyer Moderna...